Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)

Oops! Someting went wrong.

An unexpected error occurred, sorry about that. We've been notified and will get started on a fix.

Error fetching trial detail: Clinical trial not found